Ann: Appendix 3Y, page-10

This is a trading pattern preceding share price appreciations in order to maximise profits.
In many cases, such selling occurs in parallel to buying by the same entities.

OBJ has always seen selling pressure before strong price hikes.
IMO, we are in such a period, explaining director buying and a more bullish outlook from a fundamental view.

The entire push to 10 cents during last few years was, in my humble opinion, entirely premature, therefore my selling at the time as I did not see such levels to be sustainable.

The current story is interesting from a trading point of view with biotech small caps on the horizon for a broader trade move, as I see it.
I position myself accordingly and have in fact bought back several mil of OBJ and will continue to do so.